Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion type Assertion NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_head.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion description "[Based on MSI, and CIN, 3 classes were defined: (i) High microsatellite instability MSI-H tumors: young age, high carcinoembryonic antigen (CEA) level, right colon, poorly differentiated, mucin production, high BRAF mutation, lower allelic loss and relatively good prognosis; (ii) Microsatellite stability (MSS) diploid tumors: right colon, poorly differentiated, less infiltrative tumor, mucin production, lower allelic loss and low p53, BRAF mutation; (iii) MSS aneuploid tumors: more infiltrative invasion, greater allelic loss and high p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_provenance.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion evidence source_evidence_literature NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_provenance.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion SIO_000772 16231316 NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_provenance.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion wasDerivedFrom befree-20140225 NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_provenance.
- NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_assertion wasGeneratedBy ECO_0000203 NP387279.RAr8U4V97R_6sg0lFrvQmz5WO2Mk5HLKa_YNiHmqvhSh8130_provenance.